The FDA announced that it has accepted the supplemental sNDA for roflumilast foam 0.3% in those with scalp and body psoriasis over 12.

Having a dry, flaky scalp is one of the most frustrating scalp concerns to deal with. Whether from suffering from psoriasis ...

Plaque psoriasis, the most common form of psoriasis (about 90 per cent of cases), is a chronic inflammatory autoimmune ...

Does your hair's length affect how you take care of, maintain, and stop scalp psoriasis from returning? Let's talk about it.

The unique formulation of Zoryve foam is potentially a transformative new treatment option, if approved, for those living with scalp and body psoriasis.” Treatment emergent adverse events ...

Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2–3 ...

emphasized the impact of scalp psoriasis on quality of life and the effectiveness of Sotyktu as a once-daily oral treatment. Daniel Quirk, senior vice president, highlighted the potential of ...

The registry data showed significant decreases in disease severity measures after six months of treatment. Dr. Mark Lebwohl, an investigator and paid consultant for Bristol Myers Squibb, emphasized ...